Immunoglobulin D (IgD) is the least studied of immunoglobulin classes. This study sought to investigate the potential relationship between demographic, metabolic, lifestyle and immunological factors, and serum IgD concentrations in a general adult population. We measured serum IgD concentrations by means of a commercial turbidimetric assay in 413 individuals (median age, 55 years; 45% males), randomly selected from the adult population of a Spanish municipality. Serum IgD concentrations displayed considerable variation in the population, ranging from undetectable (<6.7 mg/l) to 878 mg/l. Serum IgD concentrations were undetectable in 78 cases (18.9%) and >100 mg/l in 39 cases (9.4%). Median IgD was 21.9 mg/l. Serum IgD concentrations were negatively associated with age and positively associated with smoking, after adjustment for potential confounders. Overweight individuals showed lower concentrations of IgD than did normal-weight individuals. Atopy (positivity of skin tests to aeroallergens) was not significantly associated with IgD concentrations, although non-symptomatic atopics showed higher IgD concentrations. No consistent association was observed between serum IgD concentrations and gender, metabolic syndrome, or alcohol consumption. No significant association was found between baseline IgD concentrations and development of either allergic or immune disease after a median 11.4 years of follow-up. In conclusion, serum IgD concentrations in adults show a wide variation in the population and may be influenced by common factors, particularly age and smoking habit. These factors should be taken into account when defining reference ranges for serum IgD concentrations.
Introduction
Immunoglobulin D (IgD) was discovered in a patient with myeloma more than 50 years ago [1] and remains as the most enigmatic of immunoglobulin classes [2] [3] [4] [5] [6] [7] . Whereas IgG, IgA, IgM and IgE functions have been well described, IgD function is largely unknown [2, 4, 6, 7] . IgD exists in two forms. On the one hand, IgD is coexpressed with IgM on the surface of mature B cells before antigenic stimulus, as a receptor for that antigen [3, 6, 7] , and on the other, free IgD circulates in the blood where it represents <1% of total immunoglobulin content. Serum IgD concentrations are far lower than those of IgG, IgA or IgM, but higher than those of IgE [3, 6, 7] . Serum IgD can participate in anti-infectious immunity and immune regulation, as described in recent reviews [3, 6, 7] . Serum IgD concentrations are less studied than concentrations of other immunoglobulin classes. The levels are elevated in rare IgD myelomas and may also be elevated in a variety of infectious, inflammatory and autoimmune diseases, as well as in some immunodeficiency disorders [3, 6, 7] . Increased serum concentrations of total IgD [8] [9] [10] and IgD specific to allergens [11] have been reported in patients with allergic respiratory diseases, the most common immune-based disorders in developed countries, although these findings are not consistent across all studies [12, 13] . The clinical significance of IgD in these disorders is unknown.
The potential influence of demographic, metabolic and lifestyle factors on IgD concentrations has also been little studied. In addition, the methods for IgD determination have varied across studies and have been less standardized than methods for measuring other immunoglobulin classes [7] , probably because IgD concentrations are less frequently required in clinical practice [7] . In normal individuals, dispersion of serum IgD values is higher than those of other immunoglobulins, ranking from undetectable to several hundreds of milligrams per litre [6, 7] . The potential influence of age and gender on IgD concentrations is controversial. In some studies, serum IgD concentrations were positively correlated with age in children up to age 14 years [14] and then steadily decreased with age in adults [15, 16] . However, decreasing IgD concentrations with age were either not confirmed by other authors [12, 17, 18] or found to be restricted to females [19] . Some studies have reported that serum IgD concentrations are higher in males than in females [19] , but this finding is not uniform [18] . Recent reviews conclude that there is no evidence of a significant influence of age or sex on serum IgD concentrations [6] . In terms of lifestyle, there have been reports of smoking being associated with higher IgD concentrations [19, 20] , although the association has not been observed in other studies [21] . To the best of our knowledge, no study has investigated the potential influence of alcohol consumption on serum IgD concentrations. Alcohol consumption is associated with smoking in the population and can influence serum concentrations of other immunoglobulins, such as IgA and IgE [22] [23] [24] . Similarly, no study has investigated the potential influence on IgD concentrations of common obesity-related metabolic abnormalities, which are associated with higher concentrations of IgA and IgM [22] .
It should be noted that studies which have addressed serum IgD concentrations to date have been conducted on highly selected samples, and many of them have used nonstandardized methods for IgD determination. To our knowledge, no study on IgD has relied on general adult populations. Determining the distribution of a given parameter in general populations is important for interpreting reference values. The common guidelines for definition and determination of reference intervals in the clinical laboratory advocate partitioning when differences are present among subgroups defined by age, gender or common exposures such as smoking or alcohol consumption [25] . These differences can be measured from a general population standpoint. Accordingly, this study set out to investigate the potential influence of demographics and common lifestyle, metabolic and immunological factors on serum IgD concentrations in a general adult population.
Methods
Study population and design. This observational study forms part of a cross-sectional survey of the general adult population in the town of A Estrada (north-western Spain). Detailed descriptions of methodology and population characteristics have been reported elsewhere [23] . Briefly, an age-stratified random sample (n = 720) of the adult population (>18 years) of the municipality was drawn from the Health Care Registry, which covers >95% of the population. A total of 469 individuals were studied between January 2000 and January 2001. Frozen serum samples for IgD determination were available for 413 of these individuals. The median age of participants was 55 years (range 18-92 years), and 186 (45.0%) were males. All participants were Caucasians. Non-participants (individuals with unavailable sample due to serum exhaustion, n = 56) had a similar age (median, 53 years, range 20-85 years) and gender distribution (35.7% males). Furthermore, the proportion of smokers among nonparticipants (18.0%) was similar to that of participants. The clinical records of all participants were examined in 2011 for new-onset immune diseases, infectious diseases and causes of death. Two individuals were lost to followup. A total of 81 individuals died during the study period. Median follow-up was 137 months (range, 2-142 months). The studies were reviewed and approved by the Institutional Review Board of the Complejo Hospitalario Universitario from Santiago de Compostela and the Ethics Committee from Galicia, Spain. Informed consent was obtained from each study participant in accordance with the current Helsinki Declaration.
Tobacco and alcohol consumption. Consumers of at least one cigarette per day were considered smokers. Individuals who had quit smoking during the preceding year were still considered smokers, while those who had quit more than one year prior to the study were considered ex-smokers. Individuals with an habitual tobacco consumption of one to nine cigarettes/day were defined as light smokers, and those with an habitual tobacco consumption of >9 cigarettes/day were defined as heavy smokers. Alcohol consumption was evaluated in standard drinking units [26] , by summing the number of glasses of wine (~10 g), bottles of beer (~10 g) and units of spirits (~10 g) habitually consumed per week. Individuals with an alcohol consumption of 1-140 g/week were considered light drinkers, those with an alcohol consumption of 141-280 g/week were considered moderate drinkers, and those with an alcohol consumption >280 g/week were considered heavy drinkers. Alcohol abstainers or very occasional alcohol drinkers were included in the same group.
Metabolic disorders. Body mass index (BMI) was calculated as weight (in kg) divided by the square of height (in metres). Data for calculation of BMI were unavailable in one individual. Participants were classified following the World Health Organization criteria as normal weight (BMI 18.5-24.9 kg/m . There was only an underweight (<18.5 kg/m 2 ) individual who was excluded for analyses including BMI categories. Individuals were classified as having metabolic syndrome when they met at least three of the following Adult Treatment Panel III criteria [28] : (1) abdominal obesity (waist circumference >102 cm in males or >88 cm in females); (2) hypertriglyceridaemia (fasting serum triglycerides ≥150 mg/dl); (3) low HDL cholesterol levels (fasting HDL cholesterol <40 mg/dl in males or <50 mg/dl in females); (4) increased blood pressure (arterial blood pressure ≥130/ ≥85 mmHg or current antihypertensive medication use); and (5) hyperglycaemia (fasting serum glucose ≥110 mg/dl or current antidiabetic therapy). Individuals who met at least three of these criteria were classified as having metabolic syndrome. Routine laboratory determinations were performed with an Olympus AU-400 analyser (Olympus, Tokyo, Japan).
Atopy traits. All individuals underwent skin prick tests (SPTs) with a panel of relevant aeroallergens in the area, which included mites (Dermatophagoides pteronyssinus, Lepidoglyphus destructor and Tyrophagus putrescentiae), pollens (Lolium perenne, Plantago lanceolata, Betula alba and Parietaria judaica), moulds (Alternaria alternata, Aspergillus spp., Penicillium notatum and Cladosporium herbarum) and animal danders (dog and cat) (ALK-Abell o, Spain). Wheals >3 mm after 15 min were considered positive. A detailed description of the SPT profile in this study population has been reported elsewhere [29] . The presence of at least one positive SPT was deemed to be indicative of atopy [30] . Atopic individuals were further classified according to lifetime history of upper respiratory symptoms, which was investigated at baseline in all participants by means of the questions (1) 'have you ever had a problem with sneezing or a runny or blocked nose when you did not have a cold or the flu?' and (2) 'have you ever had wheezing or whistling in the chest at any time in the past?', thereby exploring the presence of nasal and bronchial symptoms, respectively. Subjects who answered 'yes' to either of these questions were classified as symptomatic [29] .
Serum immunoglobulin assays. Serum samples were collected at baseline and stored frozen at À40°C. IgD was measured by turbidimetry using a commercially available kit (The Binding Site Limited, Birmingham, UK) in a SPAPLUS analyser (The Binding Site), in strict accordance with the manufacturer's instructions. The IgD antigen concentration was measured by turbidimetric methods, using latex-enhanced antibodies to increase the relative light-scattering signal of the antigen-antibody reaction, thereby raising the sensitivity to 6.7 mg/l. The device has been standardized against Human Serum IgD NIBSC 67/ 037 British Reference Standard.
According to the information provided by the manufacturer, there is 100% agreement between the automated IgD assay and Human Immunoglobulin D Bindarid Serum concentrations of total IgG, IgA and IgM were determined by a commercial nephelometry assay using a BN-II device (Dade Behring, Marburg, Germany) and are reported elsewhere [22] . Serum concentrations of IgG4 were determined by commercial turbidimetry (The Binding Site) [31] . Serum concentrations of total IgE were determined by commercial chemiluminescent enzyme immunoassay (Immulite, Siemens Medical Solutions, Gwynedd, UK), as reported elsewhere [23] .
Statistical analyses. We used the chi-square test to compare proportions, the Mann-Whitney, Kruskal-Wallis and Jonckheere-Terpstra trend tests for comparison of quantitative variables and Spearman's rank test to assess correlation. Cases with undetectable IgD concentrations were assigned an arbitrary value of zero in some analyses. Multivariate analyses were performed to investigate factors associated with the highest quartile of serum IgD. For covariates, age (in years) was introduced into the equation as a quantitative variable, and binary variables entered the equation as '1' ('present' or 'yes') or '0' ('absent' or 'no'). Dummy variables were created for variables with more than two categories, using the lowest category as reference. Covariates were forced to enter the equation in all models.
Results

Distribution of serum IgD concentrations
As can be seen from Fig. 1 , serum IgD concentrations varied widely in the population, ranging from undetectable (<6.7 mg/l) to 878 mg/l. IgD concentrations were undetectable in 78 individuals (18.9%) and higher than 100 mg/l in 39 individuals (9.4%). Median IgD was 21.9 mg/l (interquartile range, 8.8-46.0 mg/l) (Fig. 1) .
Relationship between serum IgD concentrations, age and gender Serum IgD concentrations decreased steadily with age ( Table 1 ). The median IgD concentration was four times lower in individuals aged >80 years than in those aged 18-30 years (Table 1 ). The proportion of individuals with the highest IgD concentrations decreased with age (Fig. 2) . The negative association between age and highest IgD concentrations was still present after adjustment for covariates (Table 2) .
Serum IgD concentrations were not significantly different in males than in females (Table 1) . Male gender was associated with high IgD concentrations after adjusting for age, but the association was greatly attenuated after adjustment for additional covariates (Table 2) .
Relationship between serum IgD concentrations and lifestyle factors
Serum IgD concentrations were higher in smokers (particularly, those smoking more than nine cigarettes per day) than in non-smokers (Table 1 and Fig. 3) . The association between heavy smoking and high serum IgD concentrations was still present after adjustment for covariates (Table 2) .
Serum IgD concentrations were not significantly different in alcohol drinkers than in abstainers/occasional drinkers (Table 1) . Heavy drinking (more than 280 g of alcohol per week) was associated with high IgD concentrations, but the association was attenuated after adjustment for covariates (Table 2) .
Relationship between serum IgD concentrations and metabolic abnormalities
Serum IgD concentrations were significantly lower in overweight individuals than in those with normal weight (Table 1) . However, serum IgD concentrations were not significantly different between obese and normal-weight individuals (Table 1) . Interestingly, the association between overweight and the highest IgD concentrations was still present after adjusting for age, gender and additional covariates (Table 2) . No significant association was observed between the presence of metabolic syndrome and serum IgD concentrations (Table 1) .
Relationship between serum IgD concentrations and immunological disorders
Serum IgD concentrations were not significantly different in atopic individuals (as defined by positivity of skin prick tests to aeroallergens) and in non-atopic individuals (Table 1) . However, an association between atopy and serum IgD was more evident when atopic individuals were stratified as symptomatic or non-symptomatic: the highest IgD concentrations were observed in asymptomatic atopics (i.e. individuals with positive SPT but with neither nasal nor bronchial symptoms, Figure S1 ).
There was no significant correlation between serum IgD concentrations and concentrations of IgG or IgM. There was a modest but statistically significant correlation between concentrations of IgD and those of IgA and IgE (Table 3) . Correlation between IgD and IgE was higher among non-atopic than among atopic individuals (Table 4 and Figure S2 ). Conversely, correlation between IgD and IgG4 was higher among atopic than among non-atopic individuals (Table 4) .
Seven patients developed allergic disease during followup. These included allergic rhinitis in three cases, drug allergy in three cases and Hymenoptera venom allergy in ............................................................................................................................................................... one case. No cases of newly diagnosed allergic disease developed among the 78 individuals with undetectable serum IgD concentrations at baseline. There were no significant differences in baseline IgD concentrations between the seven individuals who developed allergic disease and those who did not (median 36.6 mg/l and interquartile range 17.1-51.1 mg/l versus median 21.9 mg/l and interquartile range 8.5-46.6 mg/l, respectively, P = 0.232). Additional newly onset diseases of potential immune basis diagnosed during follow-up included thyroid disease (n = 11, mostly hypothyroidism [n = 10], with associated sarcoidosis in one case), psoriasis (n = 4), rheumatoid arthritis (n = 3), ulcerative colitis (n = 2), Still's disease (n = 1), Raynaud's phenomenon (n = 1), autoimmune thrombopenia (n = 1), small-vessel vasculitis (n = 1) and autoimmune hepatitis (n = 1). There were no significant differences in baseline IgD concentrations between the 25 individuals who developed immune disease and those who did not (median 24.5 mg/l and interquartile range 7.8-43.7 mg/l, and median 21.8 mg/l and interquartile range 8.7-47.1 mg/l, respectively, P = 0.94). No cases of recurrent infections indicative of immune deficiency were detected in the series as a whole.
Discussion
This study shows that serum IgD concentrations in adults are highly dispersed and may be influenced by demographic, lifestyle, metabolic and immunological factors. Age, gender and data regarding smoking, alcohol consumption, metabolic syndrome and atopy were available in all (n = 413) individuals. Data for calculation of body mass index (BMI) were unavailable for one individual. One additional individual with underweight (BMI < 18.5 kg/m 2 ) was excluded from analyses including BMI in categories. *Adjusted for age, sex, smoking, alcohol consumption and body mass index.
The wide dispersion of IgD values in normal individuals was already known [6, 7] . In this general adult population, just under 10% of individuals had IgD concentrations >100 mg/l, whereas nearly 20% of individuals had undetectable (<6.7 mg/l) serum IgD concentrations. Low serum IgD concentrations may be inherited [18] and associated with specific HLA types [32] . It has been speculated that low serum IgD is the most common immune deficiency; yet, individuals with low IgD concentrations are not prone to the classic consequences of immunoglobulin deficiency, specifically infection [32, 33] , as is confirmed by our study.
The effect of ageing on IgD concentrations in adults has proved controversial [6] . A decrease in serum IgD was observed in some studies [15, 16, 19] but not in others [12, 17, 33] . Some of these studies included small or highly selected samples with a narrow age range, for example blood donors [33] . The present study, which included individuals with a wider age range, showed a steady, significant decrease in median serum IgD with age, falling by as much as fourfold among individuals aged over 80 years in comparison with those aged 18-30 years. In fact, median IgD in our study population was half that reported by studies which included blood donors of a clearly younger age [33] . The negative effect of age remained in evidence after adjusting for potential confounders. Indeed, the negative effect of age on IgD is similar to that seen for IgE [23] and IgG4 [31] and is contrary to that observed for total IgG and IgA, which tends to increase with age [22] . The mechanisms whereby age can influence serum immunoglobulin concentrations are largely unknown. Future longitudinal studies could further confirm the effect of ageing on serum immunoglobulins. At all events, the effect of age on IgD concentrations would seem high enough for age to be considered a partitioning factor when it comes to defining reference ranges for IgD.
The effect of gender on serum IgD concentrations was not relevant in our study. Male gender was associated with higher IgD concentrations after adjustment for age. However, the association was greatly attenuated after adjusting for additional covariates, and smoking in particular. Previous studies had reported higher IgD concentrations in males [19, 33] , although not consistently [18] . Recent reviews conclude that gender is not a relevant factor for IgD concentrations [6] . Similarly, serum IgG concentrations in adults are not significantly influenced by gender [22] ; conversely, serum IgA and IgE concentrations are higher in males [22, 23] , and IgM concentrations are higher in females [22] .
In our experience, the most relevant lifestyle factor influencing serum IgD concentrations is smoking. Tobacco smoking, particularly of 10 or more cigarettes per day, was associated with high IgD concentrations after adjusting for age, gender, alcohol consumption and body mass. Median IgD among smokers of 10 or more cigarettes per day was twofold that of non-smokers. These results are consistent with some previous studies which report an enhancing effect of smoking on IgD concentrations [19, 20] . The mechanisms whereby smoking can increase serum IgD are unknown. Smoking is associated with a moderate decrease in serum IgG [22] and with increased serum IgE concentrations [23] . Both IgD and IgE participate in the immunity of mucosal surfaces, the portal of entry for smoking products. The potential correlation of IgD increase with common respiratory tract infections in smokers should be addressed in future studies. Increased IgD concentrations appear to be a consistent finding that should be included among the wide array of immune alterations associated with smoking [34] .
To the best of our knowledge, no previous study has investigated the potential influence of alcohol consumption on IgD concentrations. Alcohol is a powerful immunomodulatory drug [35, 36] and is associated with smoking in the population. Heavy drinking (of more than 280 g per week) was associated with high levels of IgD, but the association was attenuated after adjusting for covariates. Thus, the association between alcohol consumption and serum IgD is not as evident as that observed between alcohol consumption and IgA (particularly when alcoholic liver disease is present) [22] or IgE [23] in previous studies.
The presence of metabolic syndrome and obesity was not significantly associated with IgD concentrations in our study. Intriguingly, individuals with mild overweight (BMI higher than 25 kg/m 2 but lower than the threshold of 30 kg/m 2 used to define obesity) registered lower IgD concentrations than did normal-weight individuals. It is known that the association between BMI and some outcomes may be nonlinear or U-shaped [37] . In that case, confounding factors should be taken into consideration. However, the association between overweight and lower IgD concentrations was still present after adjusting for age, gender, smoking and alcohol consumption. To the best of our knowledge, there is no plausible mechanism that explains a causal relationship between overweight and lower IgD concentrations, which could be explored in further studies. It should be noted that other immunoglobulin isotypes, such as IgA, are increased in patients with obesity and metabolic syndrome [22] . In addition, serum IgM may be higher in patients with dyslipidaemia [22] .
Atopy, as defined by positive SPT to aeroallergens, was not significantly associated with serum IgD concentrations. While some previous studies indicated that serum IgD concentrations are increased in patients with respiratory allergy [8] [9] [10] , this finding was not confirmed by other studies [12, 13] . We observed some differences when atopic individuals were stratified as symptomatic (i.e. with either nasal or bronchial symptoms) and asymptomatic, with IgD concentrations being higher in the latter. Serum concentrations of IgG4 showed a similar pattern in this population [31] . Of note, IgG4 plays a tolerogenic role in allergic disorders [38] , and IgD can also block IgEmediated reactions in vitro [39] . The potential role of IgD in allergic diseases remains to be elucidated.
The present study has limitations that should be acknowledged. Classification of some exposures (such as alcohol consumption) or outcomes (such as respiratory symptoms) may be imperfect, even when validated questionnaires are used. Serum samples were kept frozen for a prolonged period prior to IgD determination. Previous reports confirmed that serum IgD concentrations are not affected by freezing and thawing [17] and IgD concentrations appear to be stable in frozen plasma after years of storage [18] . Insofar as external validity is concerned, it should be noted that all participants were Caucasians. The strengths of the study include its population-based design, random sampling and wide age range of participants; use of a reliable, standard method for IgD determination; long-term follow-up; and attempt to reduce confounding by controlling for a number of common factors. To the best of our knowledge, there have been no previous studies of a similar nature conducted on a general population.
In summary, the present study indicates that serum IgD concentrations may be influenced by common factors, particularly age and smoking, and, to a lesser extent, by alcohol consumption and overweight. The potential relationship between IgD and non-symptomatic atopy remains intriguing. From a clinical standpoint, the present results indicate that future attempts to define IgD reference ranges should take these factors into account.
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